Remedy Meds Review 2026: Pricing, Medications & How Trimi Compares

What is Remedy Meds?

Remedy's pitch is simplicity: one price that includes the prescription, licensed clinician care, unlimited video and chat access, monthly check-ins with dose adjustments, and free 48-hour cold-chain FedEx delivery. There is no separate platform fee — a real distinction from membership-model competitors, where the advertised medication price sits on top of a monthly membership charge. Our Mochi Health review covers the clearest example of that other structure.

The medication lineup, per Remedy's site as of August 2026: compounded semaglutide injection, compounded tirzepatide injection, a “GLP-1 microdose” plan (a lower dose split into twice-weekly injections, with pricing not published on the pages we reviewed), and brand-name Ozempic and Zepbound at retail pricing. Remedy states its compounded medications come from licensed U.S. compounding pharmacies and that every batch is tested for potency, sterility, pH, and endotoxin levels before shipping.

Forbes Health tested the platform in 2026 and rated it 4.3 out of 5, crediting easy onboarding and a straightforward cancellation process. This is a functioning, legitimate operation — which is exactly why the comparison worth making is not “is it real” but “what does the flexibility premium cost.”

Remedy Meds pricing vs Trimi: the verified numbers

Both programs use the same billing model — flat all-in monthly pricing, no membership fee — which makes this one of the cleaner comparisons in the category. The structural difference is commitment: Remedy prices for flexibility, Trimi prices for the full year. All Remedy figures below were verified against remedymeds.com in August 2026.

Run the 12-month math and the flexibility premium becomes concrete. A year of Remedy's compounded semaglutide at published rates — $179 for the discounted first month, then $299/month — totals $3,468. Trimi's annual plan totals $1,188, a difference of $2,280. On tirzepatide, Remedy's year runs $4,668 against Trimi's $1,500, a $3,168 gap. Remedy's warranty fine print references plans beyond month-to-month, but multi-month pricing is not published on the public product pages we reviewed — verify any prepaid rate directly with Remedy before committing, and remember that prepaying gives up part of the month-to-month flexibility that justifies the premium in the first place. Our guide to 3-month GLP-1 supplies explains how multi-month GLP-1 shipments typically work and why they usually arrive as one vial per month.

One point in Remedy's favor on pricing hygiene: it advertises a “Price Lock Guarantee,” meaning the monthly price does not climb as your prescribed dose increases — the same flat-at-every-dose approach Trimi uses. Dose-tiered pricing is one of the most common hidden-cost patterns in this market; our compounded semaglutide cost guide breaks down all four telehealth billing models, and the compounded tirzepatide cost guide covers the tirzepatide market specifically.

What Remedy Meds does well

Trade-offs to weigh before enrolling

None of these is disqualifying. They are the standard questions to resolve with any compounded GLP-1 provider — pharmacy identity first. Per FDA guidance on drug compounding, compounded drugs are not reviewed by the agency for safety, effectiveness, or quality before marketing, which is why the state-licensed pharmacy behind the vial is the single most important thing to verify, wherever you enroll.

Remedy Meds vs Ro: two different models

A lot of people comparing providers search “Ro vs Remedy,” and the honest answer is that they are not really selling the same product. As of August 2026, Ro's weight loss program centers on FDA-approved brand medications — Zepbound, Wegovy (pen and the newer pill), Ozempic, and the oral orforglipron — with a free insurance check and a concierge team that handles prior authorizations. Ro's model is built for patients who want brand medication and have a realistic path to insurance coverage; its pricing depends heavily on that coverage, so verify current rates directly with Ro.

Remedy Meds sits on the other side of the market: compounded semaglutide and tirzepatide at flat cash-pay prices, with brand options at retail pricing as a secondary lane. Compounded preparations are prepared per individual prescription by state-licensed pharmacies and are not FDA-approved as drugs — a different regulatory category from the brand products Ro leads with, with different evidence behind it.

The practical decision tree: if your insurance is likely to cover a brand GLP-1, an insurance-navigation model like Ro's is worth exhausting first. If you are cash-pay and comfortable with the compounded route after talking to a licensed provider, then compare flat all-in prices across compounded providers — that is the comparison where Remedy, Trimi, and their peers differ by thousands of dollars a year. And if you are already on a GLP-1 somewhere and weighing a move, our guide on switching GLP-1 providers covers how to change platforms without a gap in treatment.

What the clinical evidence supports

The efficacy evidence in this category comes from trials of the FDA-approved products. According to the STEP 1 trial published in the New England Journal of Medicine (2021), semaglutide 2.4 mg produced a 14.9% average body-weight reduction over 68 weeks alongside diet and exercise changes. For tirzepatide, the SURMOUNT-1 trial (NEJM, 2022) reported a 20.9% average reduction at the 15 mg dose over 72 weeks. Compounded preparations have not been studied in clinical trials of their own, and individual results vary.

Remedy's site publishes its own member outcome figures — members losing 45 lbs in their first six months on its semaglutide plan and 50 lbs on tirzepatide. Treat these as what the company says they are: self-reported data from member questionnaires, useful as a signal that the program functions, but not comparable to placebo-controlled trial results. The variable that most determines outcomes is the medication category and consistent clinical oversight — both of which are available at very different price points across providers.

Who should choose which

The verdict, plainly: Remedy Meds is a legitimate, well-built platform whose flat all-in pricing is honest about what it charges — and what it charges is a substantial premium for flexibility. Patients planning more than a few months of treatment, which describes most people who respond to GLP-1 medications, pay $2,280 to $3,168 more per year at Remedy's published rates than on Trimi's annual plan for the same medication category. Patients genuinely unsure whether they will continue past month two or three are the ones for whom Remedy's model earns its price.

Frequently asked questions